In colorectal tumor tissues, the expression of NME1 was shown to be low, and reduced NME1 was associated with higher Dukes stages, poorer differentiation, and positive lymph node metastases in CRC patients (Yang et al., 2016; Lin et al., 2011). This evidence concerns the gene NME1 and colorectal carcinoma.